OSCOTEC INC.
17Patents
16Active
17Granted
48Portfolio score
Filing activity: Mar 2, 2001 → Aug 12, 2019 · 9 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6720023B1 | Method for preparation of the supersaturated solution of calcium phosphate and the thin film of calcium phosphate crystal by using the solution | Chemistry; Metallurgy | 9 | Expired |
| US8629132B2 | Kinase inhibitors | Chemistry; Metallurgy | 8 | Active |
| US7811612B2 | Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis | Human Necessities | 7 | Active |
| US8404677B2 | Kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US8871778B2 | Substituted pyrimidine compounds and their use as SYK inhibitors | Chemistry; Metallurgy | 4 | Active |
| US7507254B2 | Inorganic bone graft materials using animal bone and method for preparing thereof | Human Necessities | 1 | Active |
| US8877763B2 | Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8053001B2 | Herbal mixture extract of Rehmanniae radix preparata and Acanthopanacis cortex and a composition comprising the same for prevention and treatment of osteoporosis | Human Necessities | 1 | Active |
| US7794760B2 | Herbal mixture extract of Pleurotus eryngii, Acanthopanacis Cortex and Notoginseng Radix and a composition comprising the same for prevention and treatment of periodontitis | Human Necessities | 0 | Active |
| US11370796B2 | Substituted pyrazoles as LRRK2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7595068B2 | Composition comprising Notoginseng radix extract for preventing and treating of arthritis as an effective ingredient | Human Necessities | 0 | Active |
| US8333998B2 | Herbal mixture extract of rehmanniae radix preparata and acanthopanacis cortex and a composition comprising the same for prevention and treatment of osteoporosis | Human Necessities | 0 | Active |
| US7879835B2 | Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyactylate derivatives | Human Necessities | 0 | Active |
| US8227456B2 | Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives | Human Necessities | 0 | Active |
| US11731969B2 | Crystal polymorph of 8-bromo-2-(1-methylpiperidin-4-ylamino)-4-(4-phenoxyphenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one hydrochloride and method for preparing same | Chemistry; Metallurgy | 0 | Active |
| US12350272B2 | Pyridopyrimidinone derivatives for use as AXL inhibitors | Human Necessities | 0 | Active |
| US9212178B2 | Substituted pyrimidine compounds and their use as SYK inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.